2385 fundamentals

Soiken Holdings Inc. is engaged in the development of biomarkers and assessment systems. It operates through the following segments: Biometric Evaluation System, Healthcare Support, Cosmetics, Dietary Supplements, and Functional Materials Development. The Biometric Evaluation System segment develops biomarkers and systems to evaluate health and illnesses, driving innovation in food and medicine for disease treatment. The Healthcare Support segment offers services on health guidance and insurance. The Cosmetics segment produces and sells cosmetics. The Dietary Supplements segment sells health supplements that include imida peptide. The Functional Materials Development segment develops and sells functional materials that include lactoferrin. The company was founded by Osami Kajimoto in July 1994 and is headquartered in Osaka, Japan.